1. Home
  2. AVDL vs TXG Comparison

AVDL vs TXG Comparison

Compare AVDL & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.63

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$16.82

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
TXG
Founded
2015
2012
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
AVDL
TXG
Price
$21.63
$16.82
Analyst Decision
Buy
Hold
Analyst Count
9
13
Target Price
$18.38
$15.42
AVG Volume (30 Days)
2.1M
2.0M
Earning Date
11-04-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$248,517,000.00
$641,814,000.00
Revenue This Year
$65.47
$4.50
Revenue Next Year
$30.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
79.88
1.92
52 Week Low
$6.38
$6.78
52 Week High
$23.57
$20.34

Technical Indicators

Market Signals
Indicator
AVDL
TXG
Relative Strength Index (RSI) 61.54 51.73
Support Level $21.36 $15.82
Resistance Level $21.68 $16.97
Average True Range (ATR) 0.12 0.81
MACD -0.12 -0.16
Stochastic Oscillator 74.68 47.22

Price Performance

Historical Comparison
AVDL
TXG

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: